Related Experiment Video
Updated: Jun 7, 2026

Functional Assessment of Intestinal Permeability and Neutrophil Transepithelial Migration in Mice using a Standardized Intestinal Loop Model
Published on: February 11, 2021
Zip14 (Slc39a14) metal transporter dysfunction leads to Akkermansia dysbiosis and inflammation in intestinal
Felix R Jimenez-Rondan1,2, Courtney H Ruggiero1, Robert J Cousins1
1Center for Nutritional Sciences, Food Science and Human Nutrition Department, College of Agricultural and Life Sciences, University of Florida, Gainesville, FL, USA.
Abstract:
Zinc is recognized as an important component of immune function in animals, operating through many different mechanisms. Metal transporter Zip14 (Slc39a14) is up-regulated during pro-inflammatory conditions and increases zinc uptake into cells, including enterocytes. As reported here, global Zip14 deletion in mice leads to excessive intestinal mucus accumulation and markedly increased fecal levels of the enteric microbe Akkermansia muciniphila. RNA sequencing showed up-regulation of a relatively small number of genes expressed in enterocytes isolated from Zip14 knockout (KO) mice. Compared to wild-type (WT) mice. Among the most up-regulated genes were St6galnac1 (ST6) and Muc2, both of which are involved in the synthesis of intestinal mucin. ATAC sequencing and ChIP assays using NF-B antibodies demonstrated that open chromatin is the likely cause of the increased expression of these mucin-forming proteins. The differences in fecal Akkermansia abundance, inflammatory cytokine expression, and St6 and Muc2 expression were alleviated in KO mice when either orally dosed with pasteurized Akkermansia or provided a single oral gavage of zinc. Collectively, these experiments show that zinc delivery via Zip14 is necessary to limit chromatin accessibility for specific regulatory factors that influence mucin production and cause dysbiosis. These findings represent an example of a genome-nutrient-microbial interrelationship.
Related Concept Videos
Dysbiosis of the Gut Microbiota
Inflammatory Bowel Disease III: Crohn's Disease
Amebiasis
Gut-Brain Axis
Microbiota Modulation by Antibiotics
Inflammatory Bowel Disease II: Ulcerative Colitis
